基于监测、流行病学和最终结果(SEER)数据库的良性垂体瘤患者发病率及预后因素
该回顾性队列研究纳入SEER数据库2004至2016年29,967例良性垂体瘤患者,计算年龄调整发病率并分析总生存相关因素。年龄调整发病率从2004年3.15/10万人年升至2011年4.66/10万人年(APC=5.51,P<0.001),2011至2016年增长趋势无统计学意义(APC=0.26,P=0.711)。手术与总生存相关(HR=0.677,95%CI:0.629-0.727),放疗与总生存无关。
要点
- 29,967例中26,691例(89.07%)存活,3,276例(10.93%)死亡。
- 年龄调整发病率2004年3.15/10万人年至2011年4.66/10万人年(APC=5.51,P<0.001)。
- 手术与总生存相关(HR=0.677,95%CI:0.629-0.727),放疗与总生存无关。
核心结论
- 良性垂体瘤总体发病率较低但呈上升趋势,手术可能有益于预后,良性垂体瘤可能不需要过度治疗如放疗。
研究设计与样本
- 回顾性队列研究,纳入SEER数据库2004至2016年报道的具有完整人口学和临床数据的良性垂体瘤患者,共29,967例。
主要发现
- 29,967例患者中26,691例(89.07%)存活,3,276例(10.93%)死亡。
- 年龄调整发病率从2004年3.15/10万人年升至2011年4.66/10万人年(年度百分比变化=5.51,P<0.001),2011至2016年增长趋势无统计学意义(年度百分比变化=0.26,P=0.711)。
- 多数患者为女性、60-79岁,垂体腺瘤占良性垂体瘤发病的主要比例。
- 多因素Cox回归模型显示手术与总生存相关(风险比=0.677,95%置信区间:0.629-0.727),Kaplan-Meier曲线同样显示该关联,尤其在垂体腺瘤中。
- 放疗与良性垂体瘤的总生存无关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To study the incidence and prognostic factors of patients with benign pituitary tumors based on the Surveillance, Epidemiology, and End Results (SEER) database. METHODS: This was a retrospective cohort study. Patients with benign pituitary tumors reported in the Surveillance, Epidemiology, and End Results database from 2004 to 2016, who presented completed demographic and clinical data, were included in our study. The age-adjusted incidence rate was calculated and stratified by year at diagnosis, age, gender, and the pathological type of benign pituitary tumor. We used Kaplan-Meier curves and multivariable Cox regressions to determine the factors associated with overall survival. RESULTS: A total of 29,967 patients were included in the study, of whom 26,691 (89.07%) survived and 3276 (10.93%) died. The age-adjusted incidence rate increased from 3.15 per 100,000 person-years in 2004 to 4.66 per 100,000 person-years in 2011 (annual percent change = 5.51, P < 0.001), and the subsequent growth trend from 2011 to 2016 was not statistically significant (annual percent change = 0.26, P = 0.711). Most patients were female, aged 60-79 years, and pituitary adenomas accounted for the main proportion of the incidence of benign pituitary tumors. Surgery was associated with the overall survival on the multivariable Cox regression model (hazard ratio = 0.677, 95% confidential interval: 0.629-0.727) and Kaplan-Meier curves, especially in pituitary adenoma. Radiation was not associated with the overall survival of benign pituitary tumor. CONCLUSIONS: The overall incidence of benign pituitary tumors was low but showed an increasing trend. Surgery may be beneficial to the prognosis. It should be noted that benign pituitary tumors may not require excessive treatment, such as radiation.
引用
- Guo X, Wu Y, Fang J, et al. Incidence and Prognostic Factors of Patients with Benign Pituitary Tumors Based on the Surveillance, Epidemiology, and End Results (SEER) Database. World Neurosurg. 2022. PMID: 35504480. doi:10.1016/j.wneu.2022.04.113
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。